The importance of ensuring close comparability between treated patients in a single-arm study and a control arm using real-world evidence is made clear by some of the less successful attempts to use RWE of efficacy in US FDA approval decisions.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?